Health Policy and Intelligence Institute

Practical insights on regulatory and policy developments in health industries

Featured - 3 items

Modernizing your pharmaceutical supply chain

3 regulatory shifts to understand

Digitizing Risk and Compliance

How AI Can Help Manage a Growing Challenge

Follow the latest health industry regulations

Read June alerts on 340B resolution, Medicare Advantage and more

As regulatory requirements evolve in the health industry, PwC’s Health Policy and Intelligence Institute helps drive proactive decision making where it matters most. The institute brings together risk and regulatory professionals and subject matter specialists to analyze the latest developments and offer guidance on what to expect, where uncertainty lies and where regulations are headed next.

Stay up to date on the latest insights by subscribing through the PwC's Preference Center below (select Health Policy and Intelligence Institute under Featured Insights).

Get started with PwC's preference center

Our insights. Your choices.

Contact us

Kelly Griffin, PhD, RAC

Director, Health Policy and Intelligence Institute, PwC US

Tiffany Gallagher

Principal, Health Industries, Cyber, Risk & Regulatory Leader, PwC US

Dave Merriam

Partner, Health Services, Cyber, Risk & Regulatory Sector Leader, PwC US

Brian Riewerts

Principal, Pharmaceutical and Life Sciences, Cyber, Risk and Regulatory Leader, PwC US

Trust solutions Consulting Tax services Newsroom Alumni US offices Contact us

© 2017 - 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.